The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 343:580-581 August 24, 2000 Number 8
NextNext

Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Gottlieb, S. S.
-Related Article
by Gress, T. W.
-PubMed Citation
To the Editor: Gress et al. (March 30 issue)1 report the findings of a study of the risk factors for type 2 diabetes mellitus associated with hypertension and antihypertensive therapy. The authors report that beta-blockers increase the risk of diabetes by 28 percent in patients with hypertension. I would like to point out some caveats and other issues that were not mentioned in the article. First, it must be noted that this increased risk is lower than that commonly perceived to be associated with this class of medications. As Sowers and Bakris note in their accompanying editorial, beta-blockers have proven . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.